Traub Capital Management’s Sanofi SNY Stock Holding History

Traub Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,050	Closed	-$50.7K	–	472
2025 Q2	$50.7K	Buy	+1,050	New	+$53.6K	0.05%	231

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Traub Capital Management's SNY Position: Q3 2025 in Review

Traub Capital Management sold out of Sanofi (SNY) in Q3 2025, closing a stake of 1,050 shares — an estimated $50.7K sold.

Traub Capital Management first reported a position in SNY in Q2 2025 and held it in 1 quarter. The position peaked at $50.7K in Q2 2025. 710 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

Traub Capital Management reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
Traub Capital Management sold 1,050 Sanofi shares in Q3 2025, an estimated $50.7K.
Traub Capital Management first reported a position in Sanofi in Q2 2025 and held it in 1 quarter.
Traub Capital Management's Sanofi position peaked at $50.7K in Q2 2025.
710 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Traub Capital Management's 13F filing for Q3 2025, filed 30 Oct 2025.